It induces the oxidative phosphorylation (OXPHOS) and tricarboxylic acid (TCA) cycle and inhibits epithelial to mesenchymal transition (EMT) and vascular endothelial growth factor (VEGF) levels in breast cancer [193]. The gene discussed is VEGFA; the disease is breast cancer.